May 31st, 2004 - 02:00 GMT Algerian pharmaceuticals group to open capital for private investors Between 15 and 30 percent of the capital of Saidal pharmaceutical production group will be opened by the end of this year, Saidal Chief Executive Officer (CEO), Ali Aoun disclosed. Read more
